EDMONTON, AB – Aurora Cannabis Inc., a leading Canadian medical cannabis company, launched the company’s first German-cultivated medical cannabis product under the brand IndiMed. Manufactured at Aurora’s EU-GMP facility in Leuna, Germany, the new brand offers locally grown and sold medical cannabis for the country’s expanding patient base.
“Aurora is proud to deliver to the rapidly growing German market our first domestically produced medical cannabis product – a significant step forward since Germany’s move to decriminalize cannabis earlier this year,” said Michael Simon, interim president of Aurora Europe. “As one of three facilities licensed to cultivate in Germany, we are uniquely positioned to offer domestic product from our EU-GMP facility in Leuna, Germany, which operates within Aurora’s global manufacturing network. It is through our expertise in cultivation and deep commitment to science and innovation that we introduce IndiMed to the German patients.”
The product launching from the IndiMed brand is Island Sweet Skunk dried flower. Product is expected to be available on January 27. IndiMed is cultivated under GACP and EU-GMP guidelines to ensure pharmaceutical-grade quality. The flowers are harvested by hand, dried under controlled conditions, and tested in a state-of-the-art laboratory for purity and active ingredient content.
Aurora’s expertise in navigating complex European regulatory frameworks and manufacturing high-quality medical cannabis positions the company as the preferred leader to drive progress in the German market with confidence. By continually setting new global benchmarks, Aurora reinforces its status as the world’s largest medical cannabis company operating in nationally legal markets.
About Aurora Cannabis Inc.
Aurora serves medical and consumer markets across Canada, Europe, Australia and South America. The company’s adult-use brand portfolio includes Drift, San Rafael ’71, Daily Special, Tasty’s, Being and Greybeard. Medical cannabis brands include MedReleaf, CanniMed, Aurora and Whistler Medical Marijuana Co., as well as international brands, Pedanios, IndiMed and CraftPlant. Aurora also has a controlling interest in Bevo Farms Ltd., a North American supplier of propagated agricultural plants.
Aurora’s common shares trade on the NASDAQ and TSX under the symbol “ACB”.
- SEO Powered Content & PR Distribution. Get Amplified Today.
- PlatoData.Network Vertical Generative Ai. Empower Yourself. Access Here.
- PlatoAiStream. Web3 Intelligence. Knowledge Amplified. Access Here.
- PlatoESG. Carbon, CleanTech, Energy, Environment, Solar, Waste Management. Access Here.
- PlatoHealth. Biotech and Clinical Trials Intelligence. Access Here.
- Source: https://mgmagazine.com/press-releases/aurora-launches-its-first-domestically-grown-medical-cannabis-brand-in-germany/